Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley M Nitschke

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Seminars in Interventional Radiology|January 18, 2014
Percutaneous neurolytic celiac plexus blockAshley M Nitschke, Charles E Ray
Oncology Reports|October 6, 2011
The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cellsLyndsay V Rhodes, Ashley M Nitschke, H Chris Segar, et al.
Scientific Reports|July 31, 2012
Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistanceJames W Antoon, Rongye Lai, Amanda P Struckhoff, et al.
Breast Cancer Research : BCR|December 18, 2008
Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotypeChanghua Zhou, Ashley M Nitschke, Wei Xiong, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Seminars in Interventional Radiology|January 18, 2014
Percutaneous neurolytic celiac plexus blockAshley M Nitschke, Charles E Ray
Oncology Reports|October 6, 2011
The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cellsLyndsay V Rhodes, Ashley M Nitschke, H Chris Segar, et al.
Scientific Reports|July 31, 2012
Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistanceJames W Antoon, Rongye Lai, Amanda P Struckhoff, et al.
Breast Cancer Research : BCR|December 18, 2008
Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotypeChanghua Zhou, Ashley M Nitschke, Wei Xiong, et al.
Pageof 1